WallStreetZenWallStreetZen

NASDAQ: RDHL
Redhill Biopharma Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RDHL past revenue growth

How has RDHL's revenue growth performed historically?
Company
-27.94%
Industry
6.67%
Market
13.96%
RDHL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RDHL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RDHL's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RDHL earnings and revenue history

Current Revenue
$61.8M
Current Earnings
-$71.7M
Current Profit Margin
-116%

RDHL Return on Equity

Current Company
N/A
Current Industry
9.1%
Current Market
188%

Be the first to know when RDHL announces earnings.

RDHL Return on Assets

Current Company
-44%
Current Industry
4.4%
RDHL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RDHL Return on Capital Employed

Current Company
111.04%
Current Industry
10.2%
RDHL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RDHL vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RDHL$61.80M-$34.69M-$71.67M+72.84%N/A
GHSI$11.85M-$10.83M-$12.71M+83.19%N/A
PTPI$6.04M-$15.68M-$21.25M-28.56%N/A
EVOK$2.90M-$7.72M-$8.29M+405.67%N/A
JUPW$6.60M-$11.77M-$13.61M+373.56%N/A
View Top Pharmaceutical Stocks

RDHL earnings dates

Next earnings date
Jun 21, 2023

Redhill Biopharma Earnings & Revenue FAQ

What were RDHL's earnings last quarter?

On Invalid Date, Redhill Biopharma (NASDAQ: RDHL) reported Q4 2022 earnings per share (EPS) of $0.00, up 100% year over year. Total Redhill Biopharma earnings for the quarter were -$3.73 million. In the same quarter last year, Redhill Biopharma's earnings per share (EPS) was -$20.00.

If you're new to stock investing, here's how to buy Redhill Biopharma stock.

What was RDHL's earnings growth in the past year?

As of Q2 2023, Redhill Biopharma's earnings has grown year over year. Redhill Biopharma's earnings in the past year totalled -$71.67 million.

What is RDHL's earnings date?

Redhill Biopharma's earnings date is Invalid Date. Add RDHL to your watchlist to be reminded of RDHL's next earnings announcement.

What was RDHL's revenue last quarter?

On Invalid Date, Redhill Biopharma (NASDAQ: RDHL) reported Q4 2022 revenue of $12.80 million up 42.01% year over year. In the same quarter last year, Redhill Biopharma's revenue was $22.07 million.

What was RDHL's revenue growth in the past year?

As of Q2 2023, Redhill Biopharma's revenue has grown -27.94% year over year. This is 34.61 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 6.67%. Redhill Biopharma's revenue in the past year totalled $61.80 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.